Brett Froeliger
09-09-19
Dr. Brett Froelinger uses fMRI to evaluate the potential benefit of novel pharmacotherapies, behavioral interventions and non-invasive neural stimulation for treating substance-use disorder pathophysiology. He also leads the MU Cognitive Neuroscience Systems Core Facility.
Read More
